FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999921844> ?p ?o ?g. }

• W1999921844 endingPage "414" @default.
• W1999921844 startingPage "406" @default.
• W1999921844 abstract "Novel therapeutic approaches are needed in mantle cell lymphoma (MCL). We conducted a phase II study in MCL testing an intensive regimen, R-MACLO-IVAM-T, a modification of the NCI 89-C-41 protocol. Newly diagnosed patients were treated with rituximab, methotrexate, doxorubicin, cyclophosphamide, and vincristine (cycle 1) followed by rituximab, ifosfamide (and mesna), etoposide, and cytarabine (cycle 2). These two cycles were repeated once, and patients achieving complete response (CR) received maintenance thalidomide. Among the 22 patients enrolled, 21 completed two or more cycles and achieved a CR. Three patients relapsed, while 17 are alive and relapse-free after a median follow-up of 37 months (range 19–65 months). Two patients died: one from sepsis during cycle 1 and another at 38 months while in remission from MCL. The progression-free survival at 3 years was 78% (95% CI: 51–91%). These results compare favorably with previously reported outcomes suggesting that durable remissions can be achieved without myeloablative therapy." @default.
• W1999921844 created "2016-06-24" @default.
• W1999921844 creator A5031420337 @default.
• W1999921844 creator A5036314999 @default.
• W1999921844 creator A5045116344 @default.
• W1999921844 creator A5049069261 @default.
• W1999921844 creator A5060976304 @default.
• W1999921844 creator A5065012486 @default.
• W1999921844 creator A5075670801 @default.
• W1999921844 creator A5084898582 @default.
• W1999921844 date "2009-12-28" @default.
• W1999921844 modified "2023-09-23" @default.
• W1999921844 title "High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma" @default.
• W1999921844 cites W1889566095 @default.
• W1999921844 cites W1912693401 @default.
• W1999921844 cites W2001985588 @default.
• W1999921844 cites W2027362911 @default.
• W1999921844 cites W2029511375 @default.
• W1999921844 cites W2032962091 @default.
• W1999921844 cites W2033307630 @default.
• W1999921844 cites W2036242721 @default.
• W1999921844 cites W2036557515 @default.
• W1999921844 cites W2043275534 @default.
• W1999921844 cites W2078761761 @default.
• W1999921844 cites W2124235514 @default.
• W1999921844 cites W2125684345 @default.
• W1999921844 cites W2130669641 @default.
• W1999921844 cites W2151092645 @default.
• W1999921844 cites W2153569820 @default.
• W1999921844 cites W2156451974 @default.
• W1999921844 cites W2210611916 @default.
• W1999921844 cites W2316396733 @default.
• W1999921844 cites W4301341292 @default.
• W1999921844 doi "https://doi.org/10.3109/10428190903518345" @default.
• W1999921844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20038221" @default.
• W1999921844 hasPublicationYear "2009" @default.
• W1999921844 type Work @default.
• W1999921844 sameAs 1999921844 @default.
• W1999921844 citedByCount "15" @default.
• W1999921844 countsByYear W19999218442012 @default.
• W1999921844 countsByYear W19999218442015 @default.
• W1999921844 countsByYear W19999218442016 @default.
• W1999921844 countsByYear W19999218442018 @default.
• W1999921844 countsByYear W19999218442019 @default.
• W1999921844 countsByYear W19999218442020 @default.
• W1999921844 countsByYear W19999218442021 @default.
• W1999921844 crossrefType "journal-article" @default.
• W1999921844 hasAuthorship W1999921844A5031420337 @default.
• W1999921844 hasAuthorship W1999921844A5036314999 @default.
• W1999921844 hasAuthorship W1999921844A5045116344 @default.
• W1999921844 hasAuthorship W1999921844A5049069261 @default.
• W1999921844 hasAuthorship W1999921844A5060976304 @default.
• W1999921844 hasAuthorship W1999921844A5065012486 @default.
• W1999921844 hasAuthorship W1999921844A5075670801 @default.
• W1999921844 hasAuthorship W1999921844A5084898582 @default.
• W1999921844 hasConcept C126322002 @default.
• W1999921844 hasConcept C141071460 @default.
• W1999921844 hasConcept C143998085 @default.
• W1999921844 hasConcept C2776364478 @default.
• W1999921844 hasConcept C2776694085 @default.
• W1999921844 hasConcept C2776755627 @default.
• W1999921844 hasConcept C2777506904 @default.
• W1999921844 hasConcept C2778041864 @default.
• W1999921844 hasConcept C2778119113 @default.
• W1999921844 hasConcept C2779338263 @default.
• W1999921844 hasConcept C2779429289 @default.
• W1999921844 hasConcept C2779609412 @default.
• W1999921844 hasConcept C2780376820 @default.
• W1999921844 hasConcept C2780653079 @default.
• W1999921844 hasConcept C2781413609 @default.
• W1999921844 hasConcept C71924100 @default.
• W1999921844 hasConcept C90924648 @default.
• W1999921844 hasConceptScore W1999921844C126322002 @default.
• W1999921844 hasConceptScore W1999921844C141071460 @default.
• W1999921844 hasConceptScore W1999921844C143998085 @default.
• W1999921844 hasConceptScore W1999921844C2776364478 @default.
• W1999921844 hasConceptScore W1999921844C2776694085 @default.
• W1999921844 hasConceptScore W1999921844C2776755627 @default.
• W1999921844 hasConceptScore W1999921844C2777506904 @default.
• W1999921844 hasConceptScore W1999921844C2778041864 @default.
• W1999921844 hasConceptScore W1999921844C2778119113 @default.
• W1999921844 hasConceptScore W1999921844C2779338263 @default.
• W1999921844 hasConceptScore W1999921844C2779429289 @default.
• W1999921844 hasConceptScore W1999921844C2779609412 @default.
• W1999921844 hasConceptScore W1999921844C2780376820 @default.
• W1999921844 hasConceptScore W1999921844C2780653079 @default.
• W1999921844 hasConceptScore W1999921844C2781413609 @default.
• W1999921844 hasConceptScore W1999921844C71924100 @default.
• W1999921844 hasConceptScore W1999921844C90924648 @default.
• W1999921844 hasIssue "3" @default.
• W1999921844 hasLocation W19999218441 @default.
• W1999921844 hasLocation W19999218442 @default.
• W1999921844 hasOpenAccess W1999921844 @default.
• W1999921844 hasPrimaryLocation W19999218441 @default.
• W1999921844 hasRelatedWork W1994523262 @default.
• W1999921844 hasRelatedWork W1999921844 @default.
• W1999921844 hasRelatedWork W2019852837 @default.
• W1999921844 hasRelatedWork W2121694206 @default.

• next